Results 101 to 110 of about 151,653 (345)

20 transposon siRNAs make up the majority of transposon siRNAs detected in total small RNA and Ago2 RISC.

open access: yes, 2022
Small RNAs from whole flies, Ago1 RISC immunoprecipitation (IP), or Ago2 RISC IP were sequenced, size selected in silico, mapped to known Drosophila miRNAs and transposons, and normalized as a percent of total reads mapped (n = 2). Transposon siRNA reads
Michael T. Marr II (14129277)   +2 more
core   +1 more source

Determination of Gene‐Level Fitness Contributions Across the Mucin‐Utilization Network of Bacteroides thetaiotaomicron

open access: yesAdvanced Science, EarlyView.
Genome‐wide CRISPRi and RNA‐seq resolve how B. thetaiotaomicron converts host mucosal glycans into fitness. The study reveals a layered mucin‐utilization architecture in which capsular polysaccharides constrain surface access, extracellular CAZymes and peptidases show functional redundancy, and intracellular catabolic pathways create discrete metabolic
Kangsan Kim   +5 more
wiley   +1 more source

A deoxyviolacein‐based transposon insertion vector for pigmented tracer studies

open access: yesMicrobiologyOpen
Pigments provide a simple means to rapidly visually ascertain the quantities or presence of specific microbes in a complex community. The selection of pigment‐producing colonies that are simple to differentiate from common colony phenotypes provides a ...
Benjamin R. Dietz   +3 more
doaj   +1 more source

A robust transposon-endogenizing response from germline stem cells

open access: yesDevelopmental Cell, 2018
SUMMARY The heavy occupancy of transposons in the genome implies that existing organisms have survived from multiple, independent rounds of transposon invasions.
Sungjin Moon   +5 more
semanticscholar   +1 more source

Mapping transposon insertion sites in a random selection of transposon insertion mutants.

open access: yes, 2013
Mapping transposon insertion sites in a random selection of transposon insertion mutants.
Mary O’Connell Motherway (416753)   +3 more
core   +1 more source

Patient‐Derived Glioblastoma Organoids for AI‐Guided Prediction of Therapeutic Response

open access: yesAdvanced Science, EarlyView.
Patient‐derived glioblastoma organoids provide clinically relevant models that preserve tumor heterogeneity and enable integrated AI‐driven analysis of imaging, molecular, and treatment‐response data. Their convergence with advanced analytics supports predictive, personalized therapeutic strategies and may accelerate translation from patient‐specific ...
Sandbhor Puja   +15 more
wiley   +1 more source

Tumor‐Intrinsic HEXB Drives Endothelial‐To‐Mesenchymal Transition and Confers Resistance to Anti‐Angiogenic Therapy in Glioblastoma

open access: yesAdvanced Science, EarlyView.
This study elucidates how glioblastoma tumors develop resistance to anti‐VEGF therapy through endothelial‐to‐mesenchymal transition (Endo‐MT). The researchers identify a novel signaling pathway where tumor‐derived HEXB stabilizes HSP60 to drive this vascular reprogramming.
Tianqi Liu   +13 more
wiley   +1 more source

Gapless Complete Genome and Multi‐Omics Illuminate Immune Adaptation and Host‐Virus Interactions in a Coronavirus Reservoir

open access: yesAdvanced Science, EarlyView.
We present a complete T2T genome assembly for a key bat reservoir. Integrating population genomics, comparative genomics, transcriptomics, single‐cell omics, and functional assays, we resolve previously inaccessible genomic regions and identify evolutionary signatures associated with immune adaptation.
Yuting Wang   +15 more
wiley   +1 more source

Transposon-Based CAR T Cells in Acute Leukemias: Where Are We Going?

open access: yesCells, 2020
Chimeric Antigen Receptor (CAR) T-cell therapy has become a new therapeutic reality for refractory and relapsed leukemia patients and is also emerging as a potential therapeutic option in solid tumors. Viral vector-based CAR T-cells initially drove these
Chiara F. Magnani   +6 more
doaj   +1 more source

Preclinical and clinical advances in transposon-based gene therapy

open access: yesBioscience Reports, 2017
Transposons derived from Sleeping Beauty (SB), piggyBac (PB), or Tol2 typically require cotransfection of transposon DNA with a transposase either as an expression plasmid or mRNA.
J. Tipanee   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy